CONMED Corporation (CNMD)
 NYSE: CNMD · Real-Time Price · USD
 44.49
 -2.22 (-4.75%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
CONMED Market Cap
CONMED has a market cap or net worth of $1.38 billion as of October 30, 2025. Its market cap has decreased by -30.84% in one year.
Market Cap 
 1.38B
Enterprise Value 
 2.23B
1-Year Change 
 -30.84%
Ranking 
 Category 
 Stock Price 
$44.49
Market Cap Chart
Since December 1, 1998, CONMED's market cap has increased from $418.20M to $1.38B, an increase of 229.31%. That is a compound annual growth rate of 4.53%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 1.45B | -31.61% | 
| Dec 31, 2024 | 2.11B | -37.22% | 
| Dec 29, 2023 | 3.37B | 24.64% | 
| Dec 30, 2022 | 2.70B | -34.83% | 
| Dec 31, 2021 | 4.15B | 29.43% | 
| Dec 31, 2020 | 3.20B | 0.94% | 
| Dec 31, 2019 | 3.17B | 75.74% | 
| Dec 31, 2018 | 1.81B | 26.84% | 
| Dec 29, 2017 | 1.42B | 15.85% | 
| Dec 30, 2016 | 1.23B | 0.70% | 
| Dec 31, 2015 | 1.22B | -1.39% | 
| Dec 31, 2014 | 1.24B | 5.45% | 
| Dec 31, 2013 | 1.17B | 47.73% | 
| Dec 31, 2012 | 794.40M | 10.84% | 
| Dec 30, 2011 | 716.70M | -3.58% | 
| Dec 31, 2010 | 743.30M | 12.01% | 
| Dec 31, 2009 | 663.60M | -4.49% | 
| Dec 31, 2008 | 694.80M | 5.08% | 
| Dec 31, 2007 | 661.20M | 2.27% | 
| Dec 29, 2006 | 646.50M | -7.43% | 
| Dec 30, 2005 | 698.40M | -17.65% | 
| Dec 31, 2004 | 848.10M | 22.66% | 
| Dec 31, 2003 | 691.40M | 23.13% | 
| Dec 31, 2002 | 561.50M | 11.56% | 
| Dec 31, 2001 | 503.30M | 91.51% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 747.43B | 
| Johnson & Johnson | 452.18B | 
| AbbVie | 403.29B | 
| UnitedHealth Group | 316.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 217.61B |